Maryland Daily Record Maryland's trusted source for business and legal news
MedImmune Inc. of Gaithersburg, the manufacturer of the FluMist nasal spray influenza vaccident, said that it has begun shipping FluMist doses to flu vaccine distributors throughout the United States.
MedImmune expects to provide approximately 15 million – 16 million doses of its trivalent (three-strain) nasal spray flu vaccine for the 2011-2012 influenza season through a variety of private health care practices, public health departments, school-located vaccination programs, military bases, and other venues.
FluMist is the first and only nasal spray flu vaccine approved in the United States to help prevent influenza.
